Benjamin Paluch

Stock Analyst at Roth MKM

(1.35)

# 3,605

Out of 5,081 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$42.61	+52.55%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$10.32	+64.73%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$4.65	+115.05%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $42.61

Upside: +52.55%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $10.32

Upside: +64.73%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $4.65

Upside: +115.05%